Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host G protein-coupled receptors (GPCRs) and nuclear receptors for microbial metabolites are a collective group of proteins that facilitate communication between the gut microbiota and the host. This group includes GPCRs like Free fatty acid receptor 2 (FFAR2) and Free fatty acid receptor 3 (FFAR3), which sense short-chain fatty acids (SCFAs) produced by bacterial fermentation, and G protein-coupled bile acid receptor 1 (GPBAR1/TGR5), which responds to secondary bile acids (Nicholson et al., 2012). It also encompasses nuclear receptors such as the Aryl hydrocarbon receptor (AhR), which detects tryptophan-derived indoles, and the Farnesoid X receptor (FXR), a primary sensor for bile acids (Rooks & Garrett, 2016). These receptors are pivotal in regulating immune cell maturation, maintaining the intestinal epithelial barrier, and coordinating systemic energy metabolism. Dysregulation of these pathways is strongly associated with chronic inflammatory conditions, metabolic disorders like type 2 diabetes and obesity, and certain gastrointestinal cancers. Therapeutic targeting of these receptors, using agents like Obeticholic acid for FXR or Tapinarof for AhR, aims to leverage the beneficial effects of microbial signaling to treat human disease (Postler & Schierwagen, 2021). However, the widespread expression and complex cross-talk of these receptors necessitate careful drug design to avoid off-target effects and systemic toxicity.
These receptors function by binding specific microbial-derived ligands, such as short-chain fatty acids or bile acids, which induces conformational changes that trigger intracellular signaling cascades or modulate gene transcription to maintain host-microbe symbiosis (Rooks & Garrett, 2016; Postler & Schierwagen, 2021).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host G protein-coupled receptors and nuclear receptors for microbial metabolites.